The decision comes as Americans grow increasingly anxious about inflation, affordability, and the state of Trump’s economy.
A new report from ProPublica Wednesday found that for months preceding President Donald Trump’s federal takeover of Portland, ...
Imagine working for a company where they decide that nobody can take vacations days in November or December. If you had been planning on taking time off over the holidays, what would you do? Would you ...
Kansas State launched its new time and leave system on Sunday, Oct. 26, requiring all hourly employees — including students — ...
Sen. Elizabeth Warren heading to a vote at the Capitol in Washington on Oct. 9, during the government shutdown. (Kent Nishimura/Reuters) Sen. Elizabeth Warren (D., Mass.) asked payroll processing ...
Hosted on MSN
Why ADP (ADP) Stock Is Falling Today
Shares of payroll and HR services provider Automatic Data Processing (NASDAQ:ADP) fell 5.3% in the afternoon session after the company reported third-quarter results that beat analyst expectations, ...
Netflix matched top-line estimates with 17% growth in the third quarter. The company had a large one-time expense related to a Brazilian tax dispute. The ad tier continues to deliver strong growth.
The Nasdaq 100 enjoyed one of those well-timed Friday afternoon rallies (1.9% off morning trading lows) to somewhat ease ...
(NEXSTAR) — The days seem to be getting shorter and the temperatures are falling, both clear signs that we’re barreling toward winter. Before we get there, however, most of the U.S. must undergo the ...
Newsweek spoke with former White House Press Secretary Karine Jean-Pierre about her book, Independent. She served in her role from May 13, 2022 to January 20, 2025, under President Joe Biden - the ...
But the woman argued that she made her own time-off request months ago and shouldn't have to give way for the bride-to-be A woman found herself in a contentious situation with a co-worker when she ...
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) are trading lower Friday following approval of one of its treatments from the U.S.’s Food and Drug Administration. SNDX shares are retreating from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results